Indeed, CRISPR deletion studies establish that FOXA1 is essential for the reshaping of the open chromatin landscape triggered by TEAD + NOTCH inhibition in PRAD organoids (see model, Fig. 6F). The gene discussed is FOXA1; the disease is prostate adenocarcinoma.